CNBC Stock Blog
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Surprising Options Trades in TiVo Shares
- 10 Dividend Picks For Your Portfolio: Chief Investors
- 4 Thanksgiving Week Buys For Your Portfolio: Market Pros
- There's a 'Great Chance' For a Double-Dip Recession: Strategist
- Retail Earnings and Sales to Improve in Q4: Analyst
- 4 Food Stocks to Stuff in Your Portfolio: Analyst
- S&P at 1050-1200 Trading Range Next Year: Strategist
- Art Cashin: Caution 'Growing' in Financials, Dividend Moves
MOST SHARED
- 8 Retailers that Gain During the Holidays
- Get Paid Six Figures to Wear a T-Shirt?
- Dubai Spooks Investors But May Bring Buying Opportunity
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Finding the Holiday's Best Buys
- Banks Play Down Dubai Exposure, Investors Still Wary
- The Good Entrepreneur Winner
- Longer Lines, Fuller Carts This Black Friday
- Global Selloff From Dubai Woes Shows Signs of Winding Down
- Some of Dubai World's Major Holdings Around Globe
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Longer Lines, Fuller Carts This Black Friday
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
- Obama's Emission Reduction Pledge Paints Future for Autos
- Is Super Bowl Halftime Act Too Old?
- Surprising Options Trades in TiVo Shares
- EA Sports Hopes to Pump Up Sales Through Pop-Up Locations
- 8 Retailers that Gain During the Holidays
- Farrell: What's Different On This Black Friday
- Dubai Stock Selloff May Bring Buying Opportunity
- Dubai Fallout Is a Correction, Not Another Crisis: El-Erian
- Dubai's Debt Woes Signal New Era for Creditors
- Longer Lines, Fuller Carts This Black Friday
- The World's Biggest Debtor Nations
- Five Tips for Buying a Foreclosed Home
- Shoppers Hit Black Friday Sales; Budgets Pared
- Slideshow: Fantasy Christmas Gifts 2009
- EA Sports Hopes to Pump Up Sales With Pop-Ups
RSS FEED
Text Size 
CNBC News Associate
Dr. Mark Monane, senior biotech analyst at Needham & Co., named some biotech stocks that look attractive.
Recommendations:
Allos Therapeutics [ALTH
Loading...
()
]—The company has a positive last trial for treating T-cell lymphoma, bladder cancer and lung cancer. “People may be treated in the real world by the end of this year,” Monane told CNBC.
Medarex [MEDX
Loading...
()
]—The company is in its late stage programs in testing melanoma, a tough-to-treat cancer. They also have solid partnerships with Bristol-Myers [BMY
Loading...
()
], Merck [MRK
Loading...
()
] and Johnson & Johnson [JNJ
Loading...
()
].
Cubist Pharmaceuticals [CBST
Loading...
()
]
Vertex Pharmaceuticals [VRTX
Loading...
()
]—They are in their last phase in developing a treatment for Hepatitis C.
Disclosure:
No immediate information was available for Monane or his firm.
______________________________
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes